Prioritizing Patient Selection for Combination Studies to Optimize Treatments
Time: 9:00 am
day: Day Two
Details:
• Calibrate the value of personalized treatments for heterogeneous patient populations
• Refine patient selection beyond only genomic screening to consider disease progression and metastases
• Reflect on accessibility of clinical samples for screening and imaging
